Parkinson's Disease Trial, Recruiting (NCT05348837)

Parkinson's Disease Trial, Recruiting NCT05348837 Sponsor: University of Colorado, Denver Condition: Parkinson's Disease

Printed from Voxsanity (voxsanity.com.au) — NCT05348837 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Parkinsons Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are willing and able to learn how to use and take care of a wristband device that tracks your sleep
You are able to wear the wristband sleep tracker for two weeks
You are willing and able to learn how to use and take care of a headband device that tracks your sleep
You are able to wear the headband sleep tracker for two weeks
You are able to keep a daily log of your routine activities during the two-week study, such as when you sleep, eat, and take medications
You are able to hold off taking certain Parkinson's-related medications after 5:00pm for three nights in a row

Who may not be able to join:

You have been diagnosed with dementia, such as Parkinson's Disease Dementia or Dementia with Lewy Bodies
You are currently taking, or have taken within the last 30 days, a prescription sleep medication such as Zolpidem, Suvorexant, or Eszopiclone
You have been diagnosed with, or meet the criteria for, a disorder that affects your body's natural sleep-wake cycle (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Alexander Baumgartner, MD, University of Colorado, Denver

Phone: 720-848-2080

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05348837

Sponsor: University of Colorado, Denver

Phase: Not Applicable

Status: Recruiting

Condition: Parkinson's Disease

Trial contact: 720-848-2080

More information: https://clinicaltrials.gov/study/NCT05348837

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are willing and able to learn how to use and take care of a wristband device that tracks your sleep
You are able to wear the wristband sleep tracker for two weeks
You are willing and able to learn how to use and take care of a headband device that tracks your sleep
You are able to wear the headband sleep tracker for two weeks
You are able to keep a daily log of your routine activities during the two-week study, such as when you sleep, eat, and take medications
You are able to hold off taking certain Parkinson's-related medications after 5:00pm for three nights in a row

Who may not be able to join:

You have been diagnosed with dementia, such as Parkinson's Disease Dementia or Dementia with Lewy Bodies
You are currently taking, or have taken within the last 30 days, a prescription sleep medication such as Zolpidem, Suvorexant, or Eszopiclone
You have been diagnosed with, or meet the criteria for, a disorder that affects your body's natural sleep-wake cycle (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Colorado, Denver

Registry

ClinicalTrials.gov

Start date

1 May 2022

Est. completion

1 July 2025

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in total sleep time (TST) as measured by polysomnogram-capable headband

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov